Doxazosin
Back to searchMolecule Structure
Scientific Name
Doxazosin
Description of the Drug
Doxazosin is an alpha-1 adrenergic receptor used to treat mild to moderate hypertension and urinary obstruction due to benign prostatic hyperplasia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00590
http://www.drugbank.ca/drugs/DB00590
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Teva Pharmaceuticals Usa Inc, Viatris Specialty Llc, Pliva Inc, Nesher Pharmaceuticals Usa Llc, Watson Laboratories Inc, Chartwell Rx Sciences Llc, Upsher Smith Laboratories Llc, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-1 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34111 | ||
| PharmGKB | PA449407 | ||
| Human Metabolome Database | HMDB0014728 | ||
| DrugBank | DB00590 | ||
| PubChem: Thomson Pharma | 14784191 | ||
| PubChem | 3157 | ||
| Mcule | MCULE-6153348827 | ||
| LINCS | LSM-4335 | ||
| Nikkaji | J21.371C | ||
| BindingDB | 86731 | ||
| EPA CompTox Dashboard | DTXSID7022964 | ||
| DrugCentral | 954 | ||
| Guide to Pharmacology | 7170 | ||
| rxnorm | CARDURA | DOXAZOSIN | DOXAZOSIN MESYLATE |
| KEGG Ligand | C06970 | ||
| ChEBI | 4708 |
